22147-Gall Bladder Cancer-NA-1244

Gall Bladder Cancer

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: NA
USOR Number:

  • Address

2312 N Nevada Ave, Suite 400
Colorado Springs, CO 80907
P: (719) 577-2555

Search by practice name, trial titles, indicators and specific disease types.